Effective and safe treatment of acute respiratory infections is one of the urgent issues of pediatrics. The most common and primary symptom of acute and chronic respiratory diseases and one of the most frequent causes of hospital visits among both children and adults is cough. Pharmacotherapy of cough involves use of the drugs improving bronchial drainage function and restoring adequate mucociliary clearance; use of antitussive drugs when indicated; antibiotic therapy in the event of the confirmed bacterial infection. The article presents data on the use of ready-made forms of phytopreparations for respiratory diseases. In particular, it demonstrates effectiveness of plantain syrup (for dry cough) and primula syrup (for productive cough).

The prevalence rate of atopic asthma in children remains high. One of the reasons for lack of control over asthma symptoms is repeated infection. The article describes results from the study of immunomodulating medication inosine pranobex used in treatment of acute respiratory infections in children with atopic asthma. The results obtained prove the efficacy and safety of this medication. The use of this immunomodifier with antiviral activity during the period of acute respiratory infection in children with atopic asthma contributes to shortening of intoxication and catarrhal signs duration, elimination of viral agents. Key words: asthma, acute respiratory infections, immunomodifiers, inosine pranobex, children. (Pediatric Pharmacology. – 2010; 7(3):98-105)

The prevalence rate of atopic asthma in children remains high. One of the reasons for lack of control over asthma symptoms is repeated infection. The article describes results from the study of immunomodulating medication inosine pranobex used in treatment of acute respiratory infections in children with atopic asthma. The results obtained prove the efficacy and safety of this medication. The use of this immunomodifier with antiviral activity during the period of acute respiratory infection in children with atopic asthma contributes to shortening of intoxication and catarrhal signs duration, elimination of viral agents. Key words: asthma, acute respiratory infections, immunomodifiers, inosine pranobex, children . (Pediatric Pharmacology. – 2010; 7(3):98-105)